Screener
Thermo Fisher Scientific TMO Analytical Instruments — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Thermo Fisher Scientific’s 8-K, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 6:04 AM EDT
- Accession
- 0000097745-26-000138
FAQ
- What is Thermo Fisher Scientific's analytical instruments — operating income (loss)?
- Thermo Fisher Scientific (TMO) reported analytical instruments — operating income (loss) of $424M in Q2 2026.
- How has Thermo Fisher Scientific's analytical instruments — operating income (loss) changed year-over-year?
- Thermo Fisher Scientific's analytical instruments — operating income (loss) increased by 30.5% year-over-year, from $325M to $424M.
- What is the long-term trend for Thermo Fisher Scientific's analytical instruments — operating income (loss)?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's analytical instruments — operating income (loss) has grown at a 9.7% compound annual growth rate (CAGR), from $1.2B to $1.74B.
- What does analytical instruments — operating income (loss) mean?
- The profit or loss generated by the Analytical Instruments segment after deducting all operating expenses from total revenues. It measures the core operational profitability of the segment before interest, taxes, and corporate-level allocations.
Ask your AI about Thermo Fisher Scientific's analytical instruments — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude